Kailera Therapeutics raised $400M in a series A funding round co-led by Atlas Venture, Bain Capital Life Sciences, and RTW Investments to advance its portfolio of obesity drugs.
Amount Raised
$400 Million
Round Type
Series A
WalthamBiotechnologyHealth CareInvestors
Description
Kailera Therapeutics has launched with a significant backing of $400 million in series A funding to support its entry into the obesity market with acquired assets from China. The funding will help advance its innovative therapies that aim to improve quality of life and health for individuals struggling with obesity.
Quick answer
Kailera Therapeutics raised $400 Million in a Series A round, dated October 1, 2024. Investors: Lyra Capital, Atlas Venture, Bain Capital Life Sciences and RTW Investments. Kailera Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Kailera Therapeutics raise?
- Kailera Therapeutics raised $400 Million in a Series A round on October 1, 2024.
- Who invested in Kailera Therapeutics?
- Lyra Capital, Atlas Venture, Bain Capital Life Sciences and RTW Investments are named as investors in this round.
- What does Kailera Therapeutics do?
- Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity.
- Where is Kailera Therapeutics based and how big is it?
- Kailera Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 130 employees.
- Who are the decision-makers at Kailera Therapeutics?
- Fundz holds 2 contacts at Kailera Therapeutics, including the President & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Kailera Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- FOXO Technologies raised $220K on November 15, 2024.
- EMBIO Diagnostics raised $2.6M (Seed) on November 15, 2024.
- Naturbeads raised $9.9M (Series A) on November 14, 2024.
- Metsera raised $215M (Series B) on November 13, 2024.
- Prelude raised $8.1M (Seed) on November 13, 2024.
- OrthoPulse raised $4.5M (Seed) on November 13, 2024.
Who to call at Kailera Therapeutics, and when
A new round usually means Kailera Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kailera Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kailera Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kailera Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kailera Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKailera Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.